Using post-mortem tissue samples, a team of researchers from Charité - Universitätsmedizin Berlin have studied the mechanisms by which the novel coronavirus can reach the brains of patients with COVID-19, and how the immune ...
Nov 30, 2020
0
98
Breaks and rearrangements in the genome can lead to severe diseases, even if all genes remain intact. Hi-C, a method to map the three-dimensional structure of chromosomes, promises more reliable and accurate diagnoses of ...
Jul 24, 2020
0
96
Early data from a clinical study suggest that blocking the Bruton tyrosine kinase (BTK) protein provided clinical benefit to a small group of patients with severe COVID-19. Researchers observed that the off-label use of the ...
Jun 5, 2020
1
279
The first round of results from an immunological study of 149 people who have recovered from COVID-19 show that although the amount of antibodies they generated varies widely, most individuals had generated at least some ...
May 26, 2020
0
3539
An improved urine-testing system for people suffering from kidney stones inspired by nature and proposed by researchers from Penn State and Stanford University may enable patients to receive results within 30 minutes instead ...
May 22, 2020
0
288
A team of researchers from Nationwide Children's Hospital in the U.S. and Universidad de Málaga in Spain has found some clues that might explain why some young children develop stronger respiratory syncytial virus (RSV) ...
Researchers at the University of California San Diego discovered that high blood levels of RNA produced by the PHGDH gene could serve as a biomarker for early detection of Alzheimer's disease. The work could lead to the development ...
Mar 31, 2020
0
369
Most people living with HIV control the virus thanks to antiretroviral therapy (ART). Although this medication is highly effective, the presence of latent viral reservoirs in their bodies means they require lifelong therapy. ...
Feb 3, 2020
0
40
A therapy that targets the immune system showed promise for treating atopic dermatitis—the most common form of eczema—in a small proof-of-concept trial, led by scientists from the Medical Research Council Human Immunology ...
Oct 23, 2019
0
101
Cancer immunotherapies have given patients with particularly intractable cancers new hope, but not everyone benefits. One such immunotherapy, known as CAR T-cell therapy, works only in about a third of the people who take ...
Aug 28, 2019
0
131
